Su, Dan
Zhang, Dadong
Jin, Jiaoyue
Ying, Lisha
Han, Miao
Chen, Kaiyan
Li, Bin
Wu, Junzhou http://orcid.org/0000-0001-6575-1743
Xie, Zhenghua
Zhang, Fanrong
Lin, Yihui
Cheng, Guoping
Li, Jing-Yu
Huang, Minran
Wang, Jinchao
Wang, Kailai http://orcid.org/0000-0002-8211-847X
Zhang, Jianjun
Li, Fugen
Xiong, Lei
Futreal, Andrew
Mao, Weimin
Article History
Received: 27 December 2018
Accepted: 30 September 2019
First Online: 7 November 2019
Competing interests
: The authors declare the following competing interests: L.X., F.L., J.-Y.L., Y.L., and Z.X. report personal fees from 3D Medicines Inc. and have ownership interest (including patents) in the same, outside the submitted work. M. Han, B.L., D.Z., and J. Wang report personal fees from 3D Medicines Inc., outside the submitted work. Z.J. reports personal fees from BMS, AstraZeneca, Geneplus, OrigMed, and Innovent, as well as a 678 grant from Merck, outside the submitted work. No competing interests were disclosed by the other authors.